TokenPost·

Emmaus Life Sciences Reports $0.07 Q3 Loss as Revenue Falls 43.8%

Your call?

Third-quarter revenue was $1.9 million. Cash and cash equivalents totaled $1.0 million at Sept. 30, down from $2.1 million at Dec. 31, 2025.

Share

More news